Analysis of Clinical Characteristics of the Ma-lignant Tumor Patients Infected with 2019 Novel Coronavirus Omicron Variant

Abstract

Objective: To investigate the clinical characteristics and clinical outcomes of 2019 novel corona-virus Omicron variant infected malignant tumor patients. Methods: Retrospective analysis of hospitalized patients with malignant tumors infected with 2019 novel coronavirus Omicron variant in our hospital from March 20, 2022 to May 15, 2022, according to the principle of 1:1 matching in different age groups; non malignant inpatients infected with the Omicron variant of covid-19 were randomly selected from the database, divided into malignant tumor group and non malignant tumor group. The epidemiological data, laboratory data and clinical outcomes of the two groups were compared, and the effects of different treatment schemes in the malignant tumor group on clinical outcomes were analyzed. Results: A total of 142 patients were collected, including 71 patients in the malignant tumor group and 71 patients in the non malignant tumor group. The average age of patients in the malignant tumor group was 62.89 ± 12.79 years. The main clinical symptoms were cough (36.6%), fatigue (21.1%), muscle soreness (18.3%), and fever (14.1%). According to clinical classification, 39 cases (54.9%) were mild and 18 cases (25.4%) were asymptomatic. 25.4% of the patients in the malignant tumor group had hypertension, 11.3% had coronary atherosclerotic heart disease,